Cargando...

A phase II study of oral etoposide in elderly patients with small cell lung cancer.

Thirty five previously untreated patients with small cell lung cancer older than 70 years were treated with oral etoposide (800 mg/m2 over five consecutive days) every four weeks. Twenty two patients had extensive disease and 13 limited disease. The overall response rate was 71%. The median survival...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Smit, E F, Carney, D N, Harford, P, Sleijfer, D T, Postmus, P E
Formato: Artigo
Lenguaje:Inglês
Publicado: 1989
Materias:
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC461991/
https://ncbi.nlm.nih.gov/pubmed/2477908
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!